Clinical trial
A Phase III Randomized Controlled Trial of Chest CT vs Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma
NCT06526897 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Randomized Controlled Trial of Chest CT vs Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma
- Lead sponsor
- ECOG-ACRIN Cancer Research Group
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 28, 2025
- Completion date
- November 1, 2032
- Enrollment
- 1,582 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
adult pleomorphic rhabdomyosarcoma, ajcc grade 2 sarcoma, ajcc grade 3 sarcoma, alveolar soft part sarcoma, angiosarcoma, clear cell sarcoma of soft tissue, dedifferentiated liposarcoma, extraskeletal ewing sarcoma, extraskeletal myxoid chondrosarcoma, fibrosarcoma, fibrosarcomatous dermatofibrosarcoma protuberans, leiomyosarcoma, malignant peripheral nerve sheath tumor, myxofibrosarcoma, pleomorphic liposarcoma, round cell sarcoma with ewsr1-non-ets fusion, sarcoma, soft tissue sarcoma, soft tissue sarcoma of the trunk and extremities, spindle cell sarcoma, stage iii soft tissue sarcoma of the trunk and extremities ajcc v8, synovial sarcoma, undifferentiated pleomorphic sarcoma